Intractable wounds caused by calcific uremic arteriolopathy treated with bisphosphonates

Journal of the American Academy of Dermatology

Volumn 57, Issue 6, 2007, Pages 1021-1025

  Hanafusa, Takaaki ^a   Yamaguchi, Yuji ^a   Tani, Mamori ^a   Umegaki, Noriko ^a   Nishimura, Yukari ^a   Katayama, Ichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ETIDRONIC ACID; PHOSPHORUS; SEVELAMER; SULFADIAZINE SILVER;

ADULT; ARTICLE; BLOOD VESSEL CALCIFICATION; CALCIFIC UREMIC ARTERIOLOPATHY; CALCINOSIS; CASE REPORT; CHRONIC KIDNEY FAILURE; DEBRIDEMENT; DISEASE COURSE; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRUG EFFICACY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HUMAN TISSUE; LEG ULCER; LETHALITY; MECHANICAL STRESS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SEPSIS; SKIN INJURY; SKIN NECROSIS; WOUND;

CALCIPHYLAXIS; ETIDRONIC ACID; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SKIN ULCER; TREATMENT OUTCOME;

EID: 36048980874     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.06.029     Document Type: Article

References (16)

1. Trent J.T., and Kirsner R.S. Calciphylaxis: diagnosis and treatment. Adv Skin Wound Care 14 (2001) 309-312
2. Arseculeratne G., Evans A.T., and Morley S.M. Calciphylaxis-a topical overview. J Eur Acad Dermatol Venereol 20 (2006) 493-502
3. Don B.R., and Chin A.I. A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies. Clin Nephrol 59 (2003) 463-470
4. Yamanaka Y., Yokota K., Furuya K., Shichinohe R., Minagawa T., and Kimura C. Successful treatment of calcific uremic arteriolopathy with wide local excision. Clin Exp Dermatol 31 (2006) 474-475
5. Martin R. Mysterious calciphylaxis: wounds with eschar-to debride or not to debride?. Ostomy Wound Manage 50 (2004) 64-66 68-71
6. Handa S.P., and Sohi P.S. Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patients. Am J Kidney Dis 29 (1997) 812
7. Russell R., Brookshire M.A., Zekonis M., and Moe S.M. Distal calcific uremic arteriolopathy in a hemodialysis patient responds to lowering of Ca x P product and aggressive wound care. Clin Nephrol 58 (2002) 238-243
8. Nitta K., Akiba T., Suzuki K., Uchida K., Watanabe R., Majima K., et al. Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am J Kidney Dis 44 (2004) 680-688
9. Bevilacqua M., Dominguez L.J., Rosini S., and Barbagallo M. Bisphosphonates and atherosclerosis: why?. Lupus 14 (2005) 773-779
10. Negri A.L. Vascular calcifications in chronic kidney disease: are there new treatments?. Curr Vasc Pharmacol 3 (2005) 181-184
11. Shiraishi N., Kitamura K., Miyoshi T., Adachi M., Kohda Y., Nonoguchi H., et al. Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium. Am J Kidney Dis 48 (2006) 151-154
12. Mitchell D.Y., St Peter J.V., Eusebio R.A., Pallone K.A., Kelly S.C., Russell D.A., et al. Effect of renal function on risedronate pharmacokinetics after a single oral dose. Br J Clin Pharmacol 49 (2000) 215-222
13. Mazhar A.R., Johnson R.J., Gillen D., Stivelman J.C., Ryan M.J., Davis C.L., et al. Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int 60 (2001) 324-332
14. Koshiyama H., Nakamura Y., Tanaka S., and Minamikawa J. Decrease in carotid intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetes. J Clin Endocrinol Metab 85 (2000) 2793-2796
15. Jono S., Nishizawa Y., Shioi A., and Morii H. Parathyroid hormone-related peptide as a local regulator of vascular calcification: its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17 (1997) 1135-1142
16. Jono S., McKee M.D., Murry C.E., Shioi A., Nishizawa Y., Mori K., et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87 (2000) E10-E17